Bevacizumab in adjuvant treatment of non-small-cell lung cancer

被引：7
|
作者：
Weiss, Jared [1 ]
机构：
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol & Oncol, Chapel Hill, NC 27514 USA
来源：
LANCET ONCOLOGY | 2017年 / 18卷 / 12期
关键词：
PHASE-III; CISPLATIN; PLACEBO; TRIAL; CHEMOTHERAPY; VINORELBINE;
D O I：
10.1016/S1470-2045(17)30843-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：4
相关论文
共 50 条
  • [1] Bevacizumab in the treatment of non-small-cell lung cancer
    Stinchcombe, T. E.
    Socinski, M. A.
    [J]. ONCOGENE, 2007, 26 (25) : 3691 - 3698
  • [2] Bevacizumab in the treatment of non-small-cell lung cancer
    T E Stinchcombe
    M A Socinski
    [J]. Oncogene, 2007, 26 : 3691 - 3698
  • [3] Bevacizumab for the treatment of advanced non-small-cell lung cancer
    Manegold, Christian
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (05) : 689 - 699
  • [4] Bevacizumab for non-small-cell lung cancer
    Garassino, Marina Chiara
    Hollander, Lital
    Torri, Valter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13): : 1373 - 1373
  • [5] Bevacizumab in non-small-cell lung cancer: a review
    Planchard, David
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (08) : 1163 - 1179
  • [6] Adjuvant treatment of early stage non-small-cell lung cancer
    Wada, H
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (07): : 102 - 105
  • [7] Adjuvant therapy for non-small-cell lung cancer
    Kalemkerian, Gregory P.
    [J]. LANCET, 2010, 375 (9722): : 1230 - 1231
  • [8] Adjuvant chemotherapy of non-small-cell lung cancer
    Rixe, O
    LeChevalier, T
    [J]. ADJUVANT THERAPY OF CANCER VIII, 1997, 8 : 71 - 73
  • [9] Role of adjuvant chemotherapy in. the treatment of non-small-cell lung cancer
    Wilhelm, L
    Kolesar, JM
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (13) : 1365 - 1369
  • [10] New approach to postoperative adjuvant treatment in non-small-cell lung cancer
    Krzakowski, Maciej
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2007, 3 (05): : 233 - 240
12345